LabCompass

Nathan D. Sepeda

Psychology · The Ohio State University

Early career · publishing since 2019Rising activity

Publications

36

Citations

2,963

Est. group size

~4

Recurring co-author estimate

Active years

8

Publishing since 2019

Research summary
AI-generated

Nathan D. Sepeda studies the psychological effects of psychedelic substances, particularly psilocybin, examining how they affect mental health, spirituality, and behavior both in controlled clinical trials and in naturalistic (real-world) use settings. His work often uses surveys and psychometric tools (questionnaires designed to measure subjective experiences like mystical or ego-dissolution states) to track outcomes such as mood, substance use, and shame/guilt over time. This research is relevant to students interested in clinical psychology, drug policy, or the therapeutic potential of psychedelics.

Psychedelic-assisted therapy and clinical trialsPsychometric measurement of mystical/spiritual experiencesNaturalistic and longitudinal psilocybin use surveysMental health, substance use, and emotional outcomesSafety and physiological effects of psychedelics

Publication output was minimal before 2020 but has grown substantially since 2023, with a sustained higher rate of output through 2025-2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.8/year recently
17182019: 1 publication192020: 4 publications202021: 2 publications212022: 1 publication222023: 8 publications8232024: 8 publications8242025: 6 publications252026: 6 publications26
Recent publications
Publishes in
  • Journal of Psychoactive Drugs×4
  • Drug and Alcohol Dependence×3
  • PsycTESTS Dataset×3
  • Chronic Stress×2
  • Psychedelic Medicine×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile